Sara Arroyo Mühr

Sara Arroyo Mühr

Senior Research Specialist | Docent

Research group leader focusing on cancer biology, genomics, biomarkers and cancer prevention.

Visiting address: F56, Karolinska Universitetssjukjuset Huddinge, 14186 Huddinge
Postal address: H9 Klinisk vetenskap, intervention och teknik, H9 CLT Centrum för Cervixcancereliminering Arroyo Mühr, 171 77 Stockholm

About me

  • I am an Associate Professor (Docent) and Senior Research Specialist at Karolinska Institutet, where I lead the Arroyo Mühr Research Group within the Center for Cervical Cancer Elimination.

    My research focuses on HPV-related and HPV-independent cancers, combining molecular biology, cancer genomics, biomarkers, epidemiology and cancer prevention. In 2026, I was awarded an ERC Starting Grant (ESCAPE-HPV) to investigate the molecular mechanisms underlying HPV-negative cervical cancers.

    Beyond molecular cancer research, I have led the implementation of HPV self-sampling for cervical cancer screening in Ukraine during the ongoing war, through a project supported by the Union for International Cancer Control (UICC). This work reflects my commitment to translating scientific evidence into accessible cancer prevention strategies, including in conflict-affected settings.

    I also serve as Scientific Lead of the International HPV Reference Center, Coordinator of the HPV Laboratory Network (HPV LabNet), and Executive Board Member of the International Papillomavirus Society (IPVS).

Research

  • My overarching goal is to bridge fundamental cancer research, molecular diagnostics and population-based epidemiology to improve cancer prevention and early detection.

    My main research interests include:

    • Cancer biology and genomics: Molecular characterisation of HPV-negative cervical cancers and HPV-associated malignancies, including oropharyngeal cancer, using genomics, transcriptomics, epigenetics and multi-omics approaches.
    • Biomarkers of disease progression and regression: Identification and evaluation of molecular and microbiome-related biomarkers associated with HPV persistence, lesion progression, regression and cancer risk.
    • Molecular epidemiology and screening optimisation: Integration of longitudinal HPV testing data, biomarkers and population-based cancer screening registries to improve risk stratification, screening participation, follow-up and early detection.
    • HPV testing and laboratory quality assurance: Evaluation, validation and standardisation of HPV testing methods, with particular emphasis on laboratory performance, quality assurance and comparability of results across laboratories.
    • Global cancer prevention and implementation research: Evaluation and implementation of accessible HPV-based screening strategies, including self-sampling in underserved and conflict-affected settings.

Teaching

  • I serve as Educational Lead at the Center for Cervical Cancer Elimination at Karolinska Institutet, contributing to the coordination and development of educational activities within the division.

    I have led the development of the HPV Laboratory Manual, an educational resource supporting laboratory professionals in HPV detection, genotyping, testing methodologies and quality assurance. I am also actively involved in developing and delivering international online training courses and educational activities covering HPV taxonomy, molecular diagnostics, laboratory methods and quality assurance.

    My teaching activities include lectures, seminars, workshops and hands-on training in HPV biology, molecular epidemiology, cancer prevention, molecular diagnostics and bioinformatics, targeting students, researchers and healthcare professionals and laboratory specialists.

    I supervise doctoral and master's students and contribute to research training, scientific mentoring and the development of early-career researchers. Through my international roles and collaborations, I am committed to strengthening scientific education, laboratory capacity building and knowledge exchange across research and healthcare settings.

Selected publications

Articles

All other publications

Selected grants

  • ERC Starting Grant ESCAPE HPV
    European Research Council (ERC)
    1 January 2027 - 31 December 2031
    Cervical cancer prevention is built on the understanding that persistent infection with high-risk human papillomaviruses (HPV) is responsible for nearly all cervical cancers. HPV vaccination and HPV-based screening have transformed prevention, bringing the elimination of cervical cancer within reach. Yet, a small proportion of cervical cancers are HPV-negative, challenging our understanding of the disease and raising a fundamental question: are these cancers truly independent of HPV, or are we missing important aspects of their biology? ESCAPE-HPV aims to unravel the molecular characteristics and potential mechanisms underlying HPV-negative cervical cancers. Using a unique collection of cancer cases and population-based registry data, the project integrates whole-genome and exome sequencing, transcriptomics and epigenomics to investigate the molecular pathways involved in their development. By moving beyond the traditional HPV-driven model of cervical carcinogenesis, ESCAPE-HPV seeks to uncover previously unrecognised biological mechanisms, improve our understanding of cervical cancer heterogeneity and identify potential molecular markers relevant to cancer classification and diagnosis. Ultimately, the project aims to generate fundamental knowledge that may inform future approaches to cervical cancer detection and prevention, helping ensure that advances in cancer elimination do not overlook biologically distinct forms of the disease.
  • Cervical Cancers Escaping HPV Screening: A Multi-Omics Approach to Tumor Evolution and Viral Persistence
    Center for Innovative Medicine
    1 January 2026 - 31 December 2028
  • Advancing Cervical Cancer Prevention: Integrating AI for Precision Screening
    ALF Medicin
    1 January 2026 - 31 December 2026
  • Human papillomavirus self-sampling for enhancing cervical screening during the war in Ukraine
    Union for International Cancer Control
    1 September 2024 - 31 August 2026

Employments

  • Senior Research Specialist, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2024-
  • Research Coordinator, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2023-2024
  • Development Officer, ME Patologi & Cancerdiagnostik, Karolinska Universitetssjukhuset, 2022-2023
  • Research Coordinator, Department of Laboratory Medicine, Karolinska Institutet, 2020-2022
  • Postdoctoral Researcher, Department of Laboratory Medicine, Karolinska Institutet, 2016-2020
  • Phd Student, Department of Laboratory Medicine, Karolinska Institutet, 2014-2016
  • Research Assistant on Study Grant, Department of Laboratory Medicine, Karolinska Institutet, 2013-2013

Degrees and Education

  • Docent, Karolinska Institutet, 2025
  • Degree Of Doctor Of Philosophy, Department of Laboratory Medicine, Karolinska Institutet, 2016

News from KI

Events from KI